XT
NVNO

XTX Topco’s enVVeno Medical NVNO Stock Holding History

XTX Topco’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,920
Closed -$21.6K – 4203
2025
Q4 		$21.6K Buy
1,920
+719
+60% +$14K ﹤0.01% 3043
2025
Q3 		$38.1K Buy
1,201
+697
+138% +$71.2K ﹤0.01% 2219
2025
Q2 		$70.3K Sell
504
-366
-42% -$43.3K ﹤0.01% 1951
2025
Q1 		$80K Buy
+870
New +$96.9K ﹤0.01% 1911
2024
Q1 		– Sell
-323
Closed -$58K – 2162
2023
Q4 		$58K Buy
+323
New +$51.4K 0.01% 1209

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's NVNO Position: Q1 2026 in Review

XTX Topco sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 1,920 shares — an estimated $21.6K sold.

XTX Topco first reported a position in NVNO in Q4 2023 and held it in 5 quarters. The position peaked at $80K in Q1 2025. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • XTX Topco reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 1,920 enVVeno Medical shares in Q1 2026, an estimated $21.6K.
  • XTX Topco first reported a position in enVVeno Medical in Q4 2023 and held it in 5 quarters.
  • XTX Topco's enVVeno Medical position peaked at $80K in Q1 2025.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.